Mauri F, Mazzotta G, Suppa M, Frigerio M, Oppizzi M, Bossi M, Todeschini P, Sanna G, Rovelli F, Cornelli U
G Ital Cardiol. 1985 Jan;15(1):10-4.
The in-hospital mortality, the causes of death, the actuarial survival curves were compared in two subsequent groups of patients admitted to our CCU for acute myocardial infarction: the first (group A) includes 791 pts, admitted from september '67 to december '72, the second (group B) includes 542 pts admitted from january '78 to june '80. The in-hospital mortality was significantly reduced in group B (A: 186/791, 23.5%; B: 72/542, 13,3%, p less than 0.01). This could be due to a reduction of the number of deaths for cardiogenic shock (A: 71/791, 9%; B: 30/542, 5.6%; p less than 0.01) and to reduction in the mortality rate for pulmonary oedema (from 6% to 1.5%, p less than 0.01), although the frequency of pulmonary oedema was the same during the two periods (A: 205 pts, 26%; B/156 pts 29%). We did not observe any significant difference in the long-term prognosis (54 months: A 79.3%, B 71.5%). The actuarial survival curves overlapped after the 1st semester after discharge. The most frequent cause of death during follow-up was a new myocardial infarction. None in the group A and only 3% in the group B were referred to the surgeon for coronary artery bypass grafting. We conclude that, in spite of a significant reduction of the in-hospital mortality, possibly related to the evolution in diagnosis and management of the disease, the long-term survival was not improved in a non-surgically treated population with myocardial infarction.
对我院冠心病监护病房(CCU)收治的两组急性心肌梗死患者的院内死亡率、死亡原因及精算生存曲线进行了比较:第一组(A组)包括791例患者,于1967年9月至1972年12月入院;第二组(B组)包括542例患者,于1978年1月至1980年6月入院。B组的院内死亡率显著降低(A组:186/791,23.5%;B组:72/542,13.3%,p<0.01)。这可能是由于心源性休克死亡人数减少(A组:71/791,9%;B组:30/542,5.6%;p<0.01)以及肺水肿死亡率降低(从6%降至1.5%,p<0.01),尽管两个时期肺水肿的发生率相同(A组:205例,26%;B组:156例,29%)。我们未观察到长期预后有任何显著差异(54个月:A组79.3%,B组71.5%)。出院后第一学期后精算生存曲线重叠。随访期间最常见的死亡原因是再次心肌梗死。A组无人接受冠状动脉旁路移植术,B组仅3%接受该手术。我们得出结论,尽管院内死亡率显著降低,这可能与疾病诊断和治疗的进展有关,但在非手术治疗的心肌梗死患者中,长期生存率并未提高。